The British Journal of Cardiology

This site is intended for UK healthcare professionals

Sponsorship statement:
Novartis Pharmaceuticals UK Ltd has provided OmniaMed Communications Ltd with an arm’s length sponsorship towards the development of the British Journal of Cardiology Masterclasses.

Masterclass: Lipids – the good, the bad and the ugly

23 January 2024
Available for 1 CPD point(s)


Watch Dermot Neely and Paul Hamilton discuss the different biological lipid transport pathways, how we measure lipids in the blood and how to distinguish between beneficial and non-beneficial lipids, and the national guidelines for lipid management in primary and secondary prevention of cardiovascular disease.


Dr Paul Hamilton Consultant Chemical Pathologist, Belfast Health and Social Care Trust And Clinical Senior Lecturer, Centre for Medical Education, Queen’s University Belfast
Dr Dermot Neely Specialist Adviser on lipids to Academic Health Science Network – North-East and North Cumbria 

Learning objectives

    • Biological properties and pathways of lipid transport in the blood

    • Distinguishing between beneficial and non-beneficial lipids

    • Calculating cholesterol in the blood

    • National guidelines for lipid management in primary and secondary prevention of cardiovascular disease

    • Lipid-lowering drugs and their physiological mechanisms of action
    • Statin intolerance and statin-associated muscle symptoms

    Learning module instructions

    This BJC TV Learning module has a recommended award of 1 CPD credit for completion (1 hour of learning).
    Completion requires a score of at least 80%. If less time is spent learning, then you should claim a reduced credit value.
    After you have successfully completed the test you will be able to download your certificate.


    1. Moffatt RJ, Stamford B (eds). Lipid Metabolism and Health, 1st edition. Boca Raton: CRC Press, 2005.

    2. Blaha MJ et al. J Clin Lipidol 2008;2:267–2739.

    3. NHS England. Summary of National Guidance for Lipid Management for Primary and Secondary Prevention of CVD. 2022. Available from: (accessed January 2024).

    4. Stroes ES et al. Eur Heart J 2015;36:1012–1022.

    5. Feingold KR (eds). Cholesterol Lowering Drugs, 1st edition. South Dartmouth:, 2016.


    Thanks for your feedback. Please note that by including your email address, you are giving permission for us to contact you by email to help resolve any issues.